Solara Active Pharma Sciences Ltd (SOLA)

Currency in INR
641.85
-10.05(-1.54%)
Closed·
SOLA Scorecard
Full Analysis
Net income is expected to grow this year
SOLA is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
638.05657.00
52 wk Range
442.80882.80
Key Statistics
Bid/Ask
640.00 / 641.85
Prev. Close
651.9
Open
638.05
Day's Range
638.05-657
52 wk Range
442.8-882.8
Volume
88.5K
Average Volume (3m)
236.88K
1-Year Change
6.69%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
SOLA Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
566.00
Downside
-11.82%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high earnings multiple

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Solara Active Pharma Sciences Ltd Company Profile

Solara Active Pharma Sciences Limited manufactures, produces, processes, formulates, sells, imports, exports, merchandises, distributes, trades in, and deals in active pharmaceutical ingredients (API) in India, Asia Pacific, Europe, North America, South America, and internationally. The company offers APIs for amyotrophic lateral sclerosis, anesthetics, anthelmintic, anti hyperlipidemic, anti-arrhythmic agent, anti-asthmatic, anti-hypertensive, anti-inflammatory, anti-Parkinson, anti-retroviral, antibiotic, anticonvulsant, antidepressant, antifibrinolytics, antifungal, antigout agent, antihelmintic, antihistamine, antihyperlipoproteinemic, antimycotic, antifungal, antineoplastic detoxifying agent, antiprotozoal agent, antipsoriatic, antipsychotic, antitubercular, antiulcer, antiulcerative, anxiolytic, aprepitant, bile acid analogue, calcimimetic agent, cardiovascular agent, chronic alcoholism, treatment of hyperphosphatemia, hemorrheologic agent, hypercholesterolemia, hypophosphatemic agent, immune-suppressant, loop diuretic, NSAIDs, nucleoside inhibitor, OAB treatment, phenylalanine reducer, phosphate binder, reversal of neuro-muscular blocking agent, skeletal muscle relaxant, and topical anti-infectives. It also provides contract research and manufacturing services for APIs, including contract development and manufacturing, analytical services, impurity synthesis, and regulatory support. In addition, the company exports its products. The company was formerly known as SSL Pharma Sciences Limited and changed its name to Solara Active Pharma Sciences Limited in March 2017. Solara Active Pharma Sciences Limited was incorporated in 2017 and is based in Chennai, India.

Employees
2156
Market
India

Compare SOLA to Peers and Sector

Metrics to compare
SOLA
Peers
Sector
Relationship
P/E Ratio
126.0x16.4x−0.5x
PEG Ratio
1.210.150.00
Price/Book
2.8x2.9x2.6x
Price / LTM Sales
2.5x1.8x3.3x
Upside (Analyst Target)
−11.8%−1.6%42.4%
Fair Value Upside
Unlock−4.9%7.2%Unlock

Analyst Ratings

0 Buy
0 Hold
1 Sell
Ratings:
1 analysts
Overall Consensus
Strong Sell

Analysts 12-Month Price Target:

Average 566.00
(-11.82% Downside)

Earnings

Latest Release
Jul 25, 2025
EPS / Forecast
2.46 / --
Revenue / Forecast
3.19B / --
EPS Revisions
Last 90 days

SOLA Income Statement

People Also Watch

84.34
MAGL
-3.38%
4,533.90
HIAE
-0.24%
2,134.10
GLEN
-0.91%
3,741.90
TORP
+0.30%
383.10
BAJE
-0.88%

FAQ

What Stock Exchange Does Solara Active Pharma Trade On?

Solara Active Pharma is listed and trades on the India National Stock Exchange stock exchange.

What Is the Stock Symbol for Solara Active Pharma?

The stock symbol for Solara Active Pharma is "SOLA."

What Is the Solara Active Pharma Market Cap?

As of today, Solara Active Pharma market cap is 30.91B.

What Is Solara Active Pharma's Earnings Per Share (TTM)?

The Solara Active Pharma EPS (TTM) is 6.18.

When Is the Next Solara Active Pharma Earnings Date?

Solara Active Pharma will release its next earnings report on 27 Oct 2025.

From a Technical Analysis Perspective, Is SOLA a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has Solara Active Pharma Stock Split?

Solara Active Pharma has split 0 times.

How Many Employees Does Solara Active Pharma Have?

Solara Active Pharma has 2156 employees.

What is the current trading status of Solara Active Pharma (SOLA)?

As of 31 Jul 2025, Solara Active Pharma (SOLA) is trading at a price of 641.85, with a previous close of 651.90. The stock has fluctuated within a day range of 638.05 to 657.00, while its 52-week range spans from 442.80 to 882.80.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.